The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Izzy Dezu, who was in the academy set up at Shelbourne FC in Dublin, was playing for the Under 16 team on Tuesday night when he collapsed.
Feeling cold with a brisk wind and heavy showers
The Labour leader said that thousands of children would spend Christmas without a home as he pressed her over the housing crisis.